October IPO Profiles: Allogene, biotech continue to lead the way

ByVCJ Staff

16 November 2018•10 mins read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Managers

October IPO Profiles: Allogene, biotech continue to lead the way

6 Dimensions Capital

Agent Capital

Albion Capital

Andera Partners

Applied Ventures

Arboretum Ventures

ARCH Venture Partners

Astellas Venture Management

Bank of America Merrill Lynch

Barclays Wealth and Investment Management

Bay City Capital

Biomatics Capital

Coatue Management

DCVC

Fletcher Spaght Inc.

Foresite Capital

Founders Circle Capital

GGV Capital

Gilde Healthcare Partners

Granite Ventures

Gunderson Dettmer

Harmony Partners

Hatteras Venture Partners

Heritage Group

IDG Capital

Index Ventures

Industry Ventures

Jackson Square Ventures

Jefferies

Khosla Ventures

Leerink Partners

Lightspeed Venture Partners

Montreux Growth Partners

NeoMed Management

New Enterprise Associates

Novo Holdings A/S

OrbiMed Advisors

ORI Capital

Premji Invest

RA Capital

RBC Capital Markets

Salesforce Ventures

Sequoia Capital

Shasta Ventures

Stripes

SV Angel

Tao Capital Partners

Thomson Reuters

Top Tier Capital Partners

Vida Ventures